Accessibility Menu
Swedish Orphan Biovitrum Ab (publ) logo

Swedish Orphan Biovitrum Ab (publ)

(OTC) BIOVF

Current Price$48.00
Market Cap$16.60B
Since IPO (2013)+384%
5 Year+192%
1 Year+58%
1 Month+1%

Swedish Orphan Biovitrum Ab (publ) Financials at a Glance

Market Cap

$16.60B

Revenue (TTM)

SEK 28.88B

Net Income (TTM)

SEK 936.33M

EPS (TTM)

$0.29

P/E Ratio

160.37

Dividend

$0.00

Beta (Volatility)

0.17 (Low)

Price

$48.00

Volume

100

Open

$48.00

Previous Close

$48.00

Daily Range

$48.00 - $48.00

52-Week Range

$27.06 - $48.00

Estimated Earnings Date

Jul 16, 2026

BIOVF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Swedish Orphan Biovitrum Ab (publ)

Industry

Biotechnology

Employees

1,969

CEO

Guido Oelkers, PhD

Headquarters

Solna, 112 76, SE

BIOVF Financials

Key Financial Metrics (TTM)

Gross Margin

44%

Operating Margin

30%

Net Income Margin

3%

Return on Equity

3%

Return on Capital

14%

Return on Assets

1%

Earnings Yield

0.62%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$16.60B

Shares Outstanding

345.85M

Volume

100

Avg. Volume

19.516

Financials (TTM)

Gross Profit

SEK 12.29B

Operating Income

SEK 8.03B

EBITDA

SEK 10.94B

Operating Cash Flow

SEK 8.54B

Capital Expenditure

-SEK 39.90M

Free Cash Flow

SEK 8.50B

Cash & ST Invst.

SEK 1.04B

Total Debt

SEK 11.72B

Swedish Orphan Biovitrum Ab (publ) Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

SEK 7.18B

+11.1%

Gross Profit

SEK 5.44B

+11.5%

Gross Margin

75.69%

N/A

Market Cap

$16.60B

N/A

Market Cap/Employee

$8.76M

N/A

Employees

1,895

N/A

Net Income

SEK 1.32B

+50.6%

EBITDA

SEK 2.65B

+15.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

SEK 940.00M

-5.7%

Total Debt

SEK 19.06B

+35.9%

Accounts Receivable

SEK 9.28B

+35.7%

Inventory

SEK 5.08B

+30.8%

Long Term Debt

SEK 7.91B

-21.0%

Short Term Debt

SEK 11.15B

+177.9%

Return on Assets

1.13%

N/A

Return on Invested Capital

14.37%

N/A

Free Cash Flow

SEK 872.00M

-61.8%

Operating Cash Flow

SEK 1.13B

-50.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ERFSFEurofins Scientific SE
$71.73-6.52%
RCDTFRecordati Industria Chimica e Farmaceutica S.p.A.
$60.00+0.00%
CHJTFCSPC Pharmaceutical Group Limited
$1.05+0.00%
CSPCYCSPC Pharmaceutical Group Limited
$3.62+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$14.98+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$77.52+0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.04-0.02%

Questions About BIOVF

What is the current price of Swedish Orphan Biovitrum Ab (publ)?

Swedish Orphan Biovitrum Ab (publ) is trading at $48.00 per share.

What is the 52-week range for Swedish Orphan Biovitrum Ab (publ)?

Over the past 52 weeks, Swedish Orphan Biovitrum Ab (publ) has traded between $27.06 and $48.00.

How much debt does Swedish Orphan Biovitrum Ab (publ) have?

As of the most recent reporting period, Swedish Orphan Biovitrum Ab (publ) reported total debt of SEK 2.00B.

How much cash does Swedish Orphan Biovitrum Ab (publ) have on hand?

Swedish Orphan Biovitrum Ab (publ) reported SEK 98.67M in cash and cash equivalents in its most recent financial results.

What is Swedish Orphan Biovitrum Ab (publ)’s dividend yield?

Swedish Orphan Biovitrum Ab (publ) does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.